# Nucleic-Acid-Based Strategies and Nanotechnology Applications for Targeted Therapy

**Authors:** Andrea Patrizia Falanga, Stefano D’Errico

PMC · DOI: 10.3390/pharmaceutics18020256 · 2026-02-19

## Full-text entities

- **Genes:** CTSB (cathepsin B) [NCBI Gene 1508] {aka APPS, CPSB, KWE, RECEUP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ASGR1 (asialoglycoprotein receptor 1) [NCBI Gene 432] {aka ASGPR, ASGPR1, CLEC4H1, HL-1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** kidney damage (MESH:D007674), Brain Tumors (MESH:D001932), Hyperuricemia (MESH:D033461), injury to (MESH:D014947), age-related macular degeneration (MESH:D008268), cancer (MESH:D009369)
- **Chemicals:** AntimiRNA Peptide Nucleic Acids (-), Lipid (MESH:D008055), Nucleosides (MESH:D009705), calix arenes (MESH:D047250), MMAE (MESH:C495575), PNAs (MESH:D020135), ammonium (MESH:D064751), beta-Cyclodextrin (MESH:C031215), uric acid (MESH:D014527), Nucleotides (MESH:D009711), Pegaptanib (MESH:C495058), oligonucleotide (MESH:D009841)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

---
Source: https://tomesphere.com/paper/PMC12943848